Ancestry plus Traits ServiceOriginal Price: £79 Sale Price: £69
Ancestry plus Traits Service
The best DNA kit with the most comprehensive ancestry breakdown and 30+ trait reports.
- 80+ personalised reports
- Ancestry percentages (to the 0.1%)
- 2000+ geographic locations
- Health upgrade available
Dig deeper into your ancestry.
It's the most complete genetic breakdown on the market, and the most comprehensive portrait of you yet.
Discover where in the world your DNA is from across 2000+ locations — in some cases, down to the county level.
Find your people.
Open your world.
Discover people who share your DNA. From close family members to distant ones, you'll be amazed by the way your DNA relatives connect you to the world.
DNA Relative Finder (optional)
Find your matches. Compare ancestries and traits. Message relatives directly to better understand your family connection.
Trace your path back thousands of years.
Travel back in time to gain a clearer picture of where you came from, where your ancestors lived and when they lived there.
Learn when your most recent ancestors from each population lived, going back more than 8 generations.
More insights into what makes you unique.
Our genes are a lot like us: endlessly diverse, endlessly interesting, occasionally weird. Find out what makes you unique, in 30+ personalised reports.
Reports include Hair Photobleaching, Freckles, Skin Pigmentation and more.
Choose the service
|Feature||Ancestry plus Traits Service||Health plus Ancestry Service|
Ancestry plus Traits
|DNA Relative Finder|
Opt in to connect and message with people who share DNA with you.
Learn how your DNA influences your facial features, taste, smell and other traits.
|Health Predisposition reports*Learn about Considerations and Limitations for Health Predispositions Reports, Carrier Status Reports and Genetic Health Risks|
Learn how your genetics can influence your chances of developing certain health conditions.
|Carrier Status reports*Learn about Considerations and Limitations for Health Predispositions Reports, Carrier Status Reports and Genetic Health Risks|
If you are starting a family, find out if you are a carrier for certain inherited conditions.
Learn how your genes play a role in your well-being and lifestyle choices.
|Pharmacogenetics reports**Learn about Considerations and Limitations for Pharmacogenetics Reports|
Discover how your DNA may impact how your body processes certain medications with three new Pharmacogenetics reports.
|Enhanced ancestry features|
Get advanced filtering for DNA Relative Finder and access up to 5000 more DNA relatives.
|Ongoing new reports and features|
Get access to new premium reports and features throughout the year.
Frequently asked questions
The DNA Relatives feature is one of the most interactive features of 23andMe, allowing you to opt in, find and connect with genetic relatives and learn more about your family. We’re extremely confident in the percentages of shared DNA we return to customers in this feature. However, the predicted relationship provided in this feature is just that -- a prediction based on the information we have. The reason we aren’t always 100% confident in the relationship prediction is that some relationships involve similar percentages of shared DNA. For example, it’s sometimes difficult for us to distinguish between a grandparent/grandchild relationship and a half-sibling relationship based on your DNA composition alone.
We have a high confidence in the accuracy of your results and the science behind them. Our scientists test and validate each step of the process we use to estimate our customers' ancestry percentages. Importantly, we are transparent about the results of these tests, and you can read about it in our Ancestry Composition Guide
Your 23andMe reports will tell you about your genetic ancestry, and you may learn that you share recent ancestors with a group of people who identify as belonging to a particular ethnic group. However, DNA cannot estimate your “ethnicity” or your “race,” because understandings of these concepts are socially constructed and depend on context, place, and time. We recommend that you use your genetic reports together with your family history to build a complete understanding of your ancestry.
Our ability to identify a parent-child or full sibling relationship is very good. That said, it is possible for a genetic testing company to be wrong about half-siblings. The amount of genetic material shared by half-siblings is 25%, on average. However, the same amount of genetic material can also be shared between a nephew and an uncle or between a grandchild and a grandparent. When interpreting, 23andMe may make a mistake.
Stay in the know.
Keep up-to-date with new discoveries and exclusive promotions on our DNA testing kits and services.
*23andMe health predisposition reports include both reports that meet FDA requirements for genetic health risks and reports which are based on 23andMe research and have not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. Warnings & Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting of the 185delAG and 5382insC variants in the BRCA1 gene and the 6174delT variant in the BRCA2 gene. The report describes if a woman is at increased risk of developing breast and ovarian cancer, and if a man is at increased risk of developing breast cancer or may be at increased risk of developing prostate cancer. The three variants included in this report are most common in people of Ashkenazi Jewish descent and do not represent the majority of BRCA1/BRCA2 variants in the general population. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding each genetic health risk and carrier status report, visit 23andme.com/test-info/
**23andMe PGS Pharmacogenetics reports: The 23andMe test uses qualitative genotyping to detect 3 variants in the CYP2C19 gene, 2 variants in the DPYD gene and 1 variant in the SLCO1B1 gene in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. It does not describe if a person will or will not respond to a particular therapeutic and does not describe the association between detected variants and any specific therapeutic. Our CYP2C19 Pharmacogenetics report provides certain information about variants associated with metabolism of some therapeutics and provides interpretive drug information regarding the potential effect of citalopram and clopidogrel therapy. Results for SLCO1B1 and DPYD and certain CYP2C19 results should be confirmed by an independent genetic test prescribed by your own healthcare provider before taking any medical action. Warning: Test information should not be used to start, stop, or change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. The PGS test is not a substitute for visits to a healthcare professional. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medication, therefore consult with your healthcare professional before taking any medical action. For important information and limitations regarding Pharmacogenetics reports, visit 23andme.com/test-info/pharmacogenetics/